Azoxy Doai Patents (Class 514/149)
-
Publication number: 20010000511Abstract: Compounds of the formula 1Type: ApplicationFiled: December 11, 2000Publication date: April 26, 2001Inventors: Vidyasagar Vuligonda, Min Teng, Richard L. Beard, Alan T. Johnson, Yuan Lin, Roshantha A. Chandraratna
-
Patent number: 5952334Abstract: A compound of formula ##STR1## wherein Z is a tetrahydro-pyrano group selected from ##STR2## having antifungal activity in combination with other antifungal agents.Type: GrantFiled: May 19, 1998Date of Patent: September 14, 1999Assignee: Glaxo Wellcome S.A.Inventors: Jose Ruiz Gomez, Jose Marie Bueno Calderon, Silvestre Garcia-Ochoa Dorado, Maria T. Fraile Gabaldon, Julia C. Pichel, Jose Fiandor Roman, Domingo Gargallo Viola, Juan C. Cuevas Zurita, Jose L. Lavandera Diaz, Sophie Huss
-
Patent number: 5840759Abstract: The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological conditions without requiring the presence of oxygen. Also provided are methods of protecting noncancerous cells or tissues in a mammal from radiation, sensitizing cancerous cells in a mammal to chemotherapeutic agents, and protecting noncancerous cells or tissues in a mammal from chemotherapeutic agents, all by administration of the same compounds.Type: GrantFiled: March 11, 1997Date of Patent: November 24, 1998Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: James B. Mitchell, Angelo Russo, Murali C. Krishna, David A. Wink, Jr., James E. Liebmann
-
Patent number: 5837736Abstract: The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological conditions without requiring the presence of oxygen. Also provided are methods of protecting noncancerous cells or tissues in a mammal from radiation, sensitizing cancerous cells in a mammal to chemotherapeutic agents, and protecting noncancerous cells or tissues in a mammal from chemotherapeutic agents, all by administration of the same compounds.Type: GrantFiled: March 11, 1997Date of Patent: November 17, 1998Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: James B. Mitchell, Angelo Russo, Murali C. Krishna, David A. Wink, Jr., James E. Liebmann
-
Patent number: 5814667Abstract: The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological conditions without requiring the presence of oxygen. Also provided are methods of protecting noncancerous cells or tissues in a mammal from radiation, sensitizing cancerous cells in a mammal to chemotherapeutic agents, and protecting noncancerous cells or tissues in a mammal from chemotherapeutic agents, all by administration of the same compounds.Type: GrantFiled: March 11, 1997Date of Patent: September 29, 1998Assignee: United States of America as represented by the Department of Health and Human ServicesInventors: James B. Mitchell, Angelo Russo, Murali C. Krishna, David A. Wink, Jr., James E. Liebmann
-
Patent number: 5795878Abstract: A phenylazoxycyanide compound of formula I ##STR1## is useful as an antimicrobial and fungicidal composition. A method for using the antimicrobial and fungicidal compositions, and for manufacturing the compound is also disclosed.Type: GrantFiled: June 6, 1997Date of Patent: August 18, 1998Assignee: American Cyanamid CompanyInventor: Werner Simon
-
Patent number: 5714511Abstract: A method for the treatment of mammalian tissue injured or at risk of injury during sepsis or shock including the administration to a mammal a diazeniumdiolate which releases a therapeutically effective amount of nitric oxide sufficient to protect the tissue from sepsis- or shock-induced injury.Type: GrantFiled: July 31, 1995Date of Patent: February 3, 1998Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, The University of PittsburghInventors: Joseph E. Saavedra, Larry K. Keefer, Timothy R. Billiar
-
Patent number: 5650442Abstract: The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological conditions without requiring the presence of oxygen. Also provided are methods of protecting noncancerous cells or tissues in a mammal from radiation, sensitizing cancerous cells in a mammal to chemotherapeutic agents, and protecting noncancerous cells or tissues in a mammal from chemotherapeutic agents, all by administration of the same compounds.Type: GrantFiled: October 7, 1994Date of Patent: July 22, 1997Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: James B. Mitchell, Angelo Russo, Murali C. Krishna, David A. Wink, Jr., James E. Liebmann
-
Patent number: 5627175Abstract: The invention is directed to azoxycyanobenzene derivatives of the formula: ##STR1## wherein n is 0-3; each R represents halogen, nitro, cyano, alkyl, haloalkyl, alkoxy, or haloalkoxy; and each R.sup.1 and R.sup.2 represents an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, or aralkyl group. The compounds may be used as fungicides.Type: GrantFiled: July 24, 1995Date of Patent: May 6, 1997Assignee: ShellInternationale Research Maatschappij B.V.Inventor: Werner E. J. Simon
-
Patent number: 5541169Abstract: An azoxy compound represented by the following general formula ##STR1## wherein R.sub.1 denotes a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkoxy group, a lower alkoxy-lower alkoxy group or a group of the formula X.sub.1 --C.tbd.C--CH.sub.2 O-- wherein X.sub.1 is a hydrogen atom or a halogen atom;R.sub.2 denotes a hydrogen atom or a lower alkyl group;R.sub.3 denotes a hydrogen atom or a lower alkyl group;R.sub.4 denotes a hydrogen atom or a group of the formula X.sub.2 --C.tbd.C--CH.sub.2 -- wherein X.sub.2 is a hydrogen atom or a halogen atom;R.sub.5 denotes a hydrogen atom or a lower alkyl group;andn is 0 or 1.This compound has an excellent antifungal activity against fungi infectious to warm-blooded animals and fungi infectious to agrohorticultural crops or fruit trees, and is useful as a medicine, a veterinary drug and an agrohorticultural antifungal agent.Type: GrantFiled: May 10, 1994Date of Patent: July 30, 1996Assignee: Kowa Company, Ltd.Inventors: Takeo Deushi, Yoshio Takahashi, Hiroyuki Ishiwata, Yukihiro Okuno, Toshiaki Oda, Masami Shiratsuchi, Katsuhiro Yamamoto
-
Patent number: 5439897Abstract: This invention relates to certain azoxycyanobenzene derivatives of the general formula. ##STR1## in which R represents an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl or heterocyclyl group; R.sup.1 represents a halogen atom, nitro, cyano or optionally substituted alkyl, alkoxy, aryl or aryloxy group; and R.sup.2 represents a hydrogen or halogen atom, nitro, cyano or optionally substituted alkyl or alkoxy group; process for their preparation, compositions containing such compounds and their use as fungicides.Type: GrantFiled: August 16, 1994Date of Patent: August 8, 1995Assignee: American Cyanamid CompanyInventor: Werner E. J. Simon
-
Patent number: 5350744Abstract: Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.Type: GrantFiled: August 27, 1992Date of Patent: September 27, 1994Assignee: Merck Frosst Canada, Inc.Inventors: Yves Girard, Pierre Hamel
-
Patent number: 5089487Abstract: Cardioactive compounds of the formula ##STR1## in which R.sup.1 and R.sup.8 and R.sup.14 and R.sup.15 can be hydrogen or various organic radicals.Type: GrantFiled: May 24, 1990Date of Patent: February 18, 1992Assignee: Bayer AktiengesellschaftInventors: Klaus Frobel, Jan-Bernd Lenfers, Peter Fey, Andreas Knorr, Johannes-Peter Stasch, Hartwig Muller, Erwin Bischoff, Hans-Georg Dellweg
-
Patent number: 5089486Abstract: Compounds of the general formulaR--N.dbd.NX (I)or N-oxides thereof, where R represents on amidophenyl group, and X represents a cyano group, a group --COOH or a salt, ester or amino derivative thereof; are fungicidal.Type: GrantFiled: July 27, 1990Date of Patent: February 18, 1992Assignee: Shell Research LimitedInventors: William W. Wood, Thomas W. Naisby, Andrew C. G. Gray
-
Patent number: 5084448Abstract: Novel compounds of the general formula ##STR1## where R represents an optionally substituted aryl or heteroaryl group; X represents a hydrogen atom or an amino group or an optionally substituted alkyl, aryl or heteroaryl group; and Z represents a hydrogen atom or alkanoyl group; are fungicidal.Type: GrantFiled: August 1, 1990Date of Patent: January 28, 1992Assignee: Shell Research LimitedInventors: Andrew C. G. Gray, William W. Wood, Thomas W. Naisby
-
Patent number: 5057504Abstract: Pesticidal bicyclo-octanes are of the formula ##STR1## where R is a substituted or unsubstituted aliphatic or aromatic group, R' and R.sup.3 are H or a substituted or unsubstituted aliphatic or aromatic group, R.sup.2 is a substituted or unsubstituted heterocyclic group containing at least one ring nitrogen and is preferably a 3- or 4- pyridyl group, Z is CH.sub.2 CH.sub.2, CH.sub.2 O--CH.sub.2 S or COCH.sub.2 or CH(OR.sup.5)CH.sub.2 where R.sup.5 is H, alkyl, acyl or carbamoyl at Y and Y' are O or S(O).sub.m where m is 0, 1 or 2.Various methods for their preparation are described.Type: GrantFiled: August 16, 1989Date of Patent: October 15, 1991Assignee: The Wellcome Foundation LimitedInventors: Malcolm H. Black, John A. Wyatt, John B. Weston, John P. Larkin, Ian H. Smith, David A. Pulman
-
Patent number: 5057508Abstract: Bicyclo-[2,2,1]-heptanes, bicyclo-[2,2,2]-octanes and bicyclo[2,2,3]-nonanes having 2 or 3 ring hetero atoms selected from O, S and N, substituted at the 1-position by a 4-alkynylphenyl group and at the 4-position and optionally at the 3 and/or 5-position are valuable pesticides, particularly insecticides and acaracides. The compounds may be prepared by reacting an alkyne with the corresponding 4-iodophenyl substituted compound or by debromination of the corresponding 4-dibromomethylphenyl substituted compound.Type: GrantFiled: February 20, 1990Date of Patent: October 15, 1991Assignee: The Regents of the University of CaliforniaInventors: John E. Casida, Christopher J. Palmer, John P. Larkin, Ian H. Smith
-
Patent number: 5039705Abstract: This invention concerns anti-hypertensive compositions and a method of lowering blood pressure in mammals. The active component of the compositions is a compound of the formula: ##STR1## wherein R.sub.1 and R.sub.2 are independently chosen from straight chain and branched chain C.sub.1 -C.sub.12 alkyl groups and benzyl, with the proviso that no branch occur on the alpha carbon atom of the alkyl groups; or R.sub.1 and R.sub.2 together with the nitrogen atom they are bonded to form a pyrrolidino, piperidino, piperazino or morpholino group, M.sup.+ is a pharmaceutically acceptable cation, wherein X is the valence of the cation.Type: GrantFiled: September 15, 1989Date of Patent: August 13, 1991Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: Larry K. Keefer, David A. Wink, Tambra M. Dunams, Joseph A. Hrabie
-
Patent number: 5008102Abstract: Temporary, light-absorbing, ocularly biocompatible compositions include at least one biocompatible, light-absorbing substance in an amount sufficient to block substantially all light of desired wavelengths and protect susceptible ocular tissues from light induced damage, where the composition is placed introcularly between the light source and ocular tissues susceptible to damage from such light. These compositions can be used to coat or to impregnate intraocular lenses, either before or after insertion of the lenses into the eye, or can be placed intraocularly, in the anterior chamber, over the pupil, in the posterior chamber or in the capsular bag of an eye, as during an ophthalmic procedure.Type: GrantFiled: December 23, 1987Date of Patent: April 16, 1991Inventor: Kenneth K. York
-
Patent number: 4997820Abstract: Novel macrocyclic compounds of the formual I ##STR1## where the dotted line in the 9,10-position is a saturated bond or a double bond, alternatively, and R is hydrogen, methyl or certain acyl radicals, and R.sub.o is hydrogen, halogen, azido, thiol, hydroxyl or --OY, where Y is, among other radicals, an ether radical, a silyl group, a sulfonyl group, a sugar radical or a (thiol)acyl radical, and R being methyl if there is a double bond in the 9,10-position, have microbicidal properties for the control of phytopathogenic microorganisms. They can be employed in the customary formulation for the control of plant disease.Type: GrantFiled: September 8, 1989Date of Patent: March 5, 1991Assignees: Gesellschaft fur Biotechnologische Forschung mbH, Ciba-Geigy CorporationInventors: Marius Sutter, Norbert Bedorf, Gerhard Hofle, Dietmar Schummer, Bettina Bohlendorf
-
Patent number: 4981954Abstract: Novel azoxy compounds having antifungal activity and being useful for the treatment of mycoses, represented by the following formula ##STR1## are prepared by culturing a microorganism of Streptomyces sp. (KC-7367, FERM BP-1277) and separating the compounds from the culture broth.Type: GrantFiled: March 11, 1988Date of Patent: January 1, 1991Assignee: Kowa Company, Ltd.Inventors: Masahito Nakayama, Hisakatsu Ito, Isamu Watanabe, Masami Shiratsuchi
-
Patent number: 4965257Abstract: Bicyclo-[2,2,1]-heptanes, bicyclo-[2,2,2]-octanes and bicyclo-[2,2,3]-nonanes, having 2 or 3 ring hetero atoms selected from O, S and N, substituted at the 1-position by a 4-alkynylphenyl group and at the 4-position and optionally at the 3 and/or 5-position are valuable pesticides, particularly insecticides and acaracides. The compounds may be prepared by reacting an alkyne with the corresponding 4-iodophenyl substituted compounds or by debromination of the corresponding 4-dibromomethylphenyl substituted compound.Type: GrantFiled: July 24, 1989Date of Patent: October 23, 1990Assignee: The Regents of the University of CaliforniaInventors: John E. Casida, Christopher J. Palmer, John P. Larkin, Ian H. Smith
-
Patent number: 4954526Abstract: A method of treating cardiovascular disorders in a mammal, by administering to said mammal an effective amount of a compound of the formula:[R--N(H)N(NO)O--].sub.y Xwherein R is loweralkyl, aryl, arylalkyl, or cycloalkyl, any of which R groups may be optionally substituted by one to three substituents selected from the group consisting of: halo, hydroxyl, alkoxy, amino, amido, formyl, carboxyl, or nitro; and wherein X is a pharmaceutically acceptable cation, a pharmaceutically acceptable metal center, or a pharmaceutically acceptable organic group selected from loweralkyl, acyl or amido, and Y is 1 to 3 consistent with the valence of X. Pharmaceutical compositions containing the compounds are also provided.Type: GrantFiled: February 28, 1989Date of Patent: September 4, 1990Assignee: The United States of America as represented by the Department of Health and Human ServicesInventor: Larry K. Keefer
-
Patent number: 4876274Abstract: A pesticidal composition comprising a compound having the formula R--C(CH.sub.2 O).sub.3 C--X wherein R and X are each organic substituents and wherein the compound has an LD.sub.50, in micrograms of compound per gram of body weight of a selected pest, of less than about 400 and/or an LD.sub.50 in the presence of synergist of less than about 20 is disclosed along with its use in killing pests. Pesticidal activity has been found against a broad range of types of insects. The pesticidal activity of the composition is strongly enhanced by the use of a selected synergist.Type: GrantFiled: August 27, 1986Date of Patent: October 24, 1989Assignee: The Regents of the University of CaliforniaInventors: Christopher J. Palmer, John E. Casida
-
Patent number: 4814161Abstract: Complete dissolution of a wide range of drugs in chlorofluorocarbon aerosol propellents is achieved by the presence of glycerol phosphatides, preferably phosphatidylcholine.Type: GrantFiled: November 10, 1986Date of Patent: March 21, 1989Assignee: Riker Laboratories, Inc.Inventors: Philip A. Jinks, Alexander Bell, Franz X. Fischer
-
Patent number: H303Abstract: This invention describes a composition of matter and a method of treating agricultural substrates in which an active ingredient selected from the group consisting of fungicides, bactericides, insecticides, insect repellents, herbicides and plant growth regulators and mixtures thereof is utilized in conjunction with an amount of a glycoside dispersing agent selected from the group consisting of fructoside, glucoside, mannoside, galactoside, taloside, guloside, alloside, altroside, idoside, arabinsode, xyloside, lyxoside and riboside and mixtures thereof which is sufficient to form an emulsion or dispersion of the active ingredient.Type: GrantFiled: October 22, 1986Date of Patent: July 7, 1987Assignee: A. E. Staley Manufacturing CompanyInventors: Arshad H. Malik, Arno Cahn